Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;8(1):29-36.
doi: 10.21037/hbsn.2018.12.02.

Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure

Affiliations

Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure

Eyal Mor et al. Hepatobiliary Surg Nutr. 2019 Feb.

Abstract

Background: Two-stage hepatectomy (TSH) with portal vein embolization (PVE) is associated with high morbidity and mortality and may result in liver failure due to insufficient future liver remnant. The objectives of this investigation were to evaluate the short-term outcomes of patients with colorectal cancer liver metastasis who underwent TSH with PVE, and to critically review the selection criteria for TSH-PVE.

Methods: A retrospective review of all patients who were operated due to bi-lobar CRLM during the years 2007-2017 was performed. Patients who underwent TSH-PVE were compared to those who underwent right hepatectomy (RH) only.

Results: Twenty-nine patient underwent TSH, 25 of whom (86.2%) completed both stages. These patients demonstrated a major complication rate of 17%, and a 90-day mortality rate of 3.4%. Most complications (80%) were related to the colonic resection, and one patient developed liver failure. Patients who suffered complications had a trend towards more baseline comorbidities and more liver lesions. Ablative techniques were utilized in 76%. When compared to 35 patients who underwent sole RH, no significant difference was demonstrated in major complication rate (20%) or mortality (0%).

Conclusions: TSH is a relatively safe procedure in selected patients. Ablative techniques can reduce the occurrence of liver insufficiency and should be used liberally when possible. Factors such as number of lesions, comorbidities and the timing of colonic resection should be considered and evaluated in order to improve the outcomes of the procedure.

Keywords: Two-stage hepatectomy (TSH); ablation; bi-lobar; colorectal liver metastasis; patient selection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Overall survival data of the two groups. OS, overall survival; RH, right hepatectomy; TSH, two-stage hepatectomy.

Comment in

Similar articles

Cited by

References

    1. Global Burden of Disease Cancer Collaboration , Fitzmaurice C, Akinyemiju TF, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2018;4:1553-68. 10.1001/jamaoncol.2018.2706 - DOI - PMC - PubMed
    1. Littlejohns P, Tamber S, Ranson P, et al. Treatment for liver metastases from colorectal cancer. Lancet Oncol 2005;6:73. 10.1016/S1470-2045(05)01729-8 - DOI - PubMed
    1. Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:647-51. 10.1001/archsurg.1984.01390180015003 - DOI - PubMed
    1. Fortner JG, Silva JS, Golbey RB, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984;199:306-16. 10.1097/00000658-198403000-00010 - DOI - PMC - PubMed
    1. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery 1988;103:278-88. - PMC - PubMed